Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Bromocriptine (as bromocriptine mesilate) 5 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bromocriptine mesilate |
Inferred relationship |
Some |
|
Bromocriptine (as bromocriptine mesilate) 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bromocriptine mesilate |
Inferred relationship |
Some |
|
Bromocriptine (as bromocriptine mesilate) 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bromocriptine mesilate |
Inferred relationship |
Some |
|
Bromocriptine (as bromocriptine mesilate) 10 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bromocriptine mesilate |
Inferred relationship |
Some |
|
Bromocriptine (as bromocriptine mesilate) 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bromocriptine mesilate |
Inferred relationship |
Some |
1 |
Bromocriptine (as bromocriptine mesilate) 10 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bromocriptine mesilate |
Inferred relationship |
Some |
1 |
Bromocriptine (as bromocriptine mesilate) 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bromocriptine mesilate |
Inferred relationship |
Some |
1 |
Bromocriptine (as bromocriptine mesilate) 5 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bromocriptine mesilate |
Inferred relationship |
Some |
1 |
Bromocriptine (as bromocriptine mesilate) 2.5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bromocriptine mesilate |
Inferred relationship |
Some |
1 |
Bromocriptine (as bromocriptine mesilate) 10 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bromocriptine mesilate |
Inferred relationship |
Some |
1 |
Bromocriptine (as bromocriptine mesilate) 1 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bromocriptine mesilate |
Inferred relationship |
Some |
1 |
Bromocriptine (as bromocriptine mesilate) 5 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bromocriptine mesilate |
Inferred relationship |
Some |
1 |
Product containing precisely bromocriptine (as bromocriptine mesilate) 800 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bromocriptine mesilate |
Inferred relationship |
Some |
1 |